Rappta Therapeutics
PrivateLast Round
Series A
Oct 13, 2020
Total Funding Raised
$10.6M
Company Overview
Rappta Therapeutics operates in Healthcare & Life Sciences and is based in Helsinki. Its latest recorded funding round was a Series A round in October 2020.
Rappta Therapeutics is a biotechnology company that develops first-in-class anti-cancer molecular glues designed to reactivate the protein phosphatase 2A (PP2A) tumor suppressor.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rappta Therapeutics Comparables
Compare Rappta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orionis Biosciences | 81% | |
| Magnet Biomedicine | 80% | |
| Proxygen | 80% |
For institutional investors. Book with your work email.
Rappta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 13, 2020 | ||||
| Grant | Oct 13, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rappta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Business Finland | Grant, Series A |
| Advent Life Sciences | Series A |
| Novo Holdings | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 57% MoM.
- Jan 13, 2025
Partnered with SpringWorks Therapeutics for a pre-clinical molecular glue.
For institutional investors. Book with your work email.
Rappta Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rappta Therapeutics's valuation, stock price, and market status.
Is Rappta Therapeutics a public or private company?
Rappta Therapeutics is a private company.
What is the current stock price of Rappta Therapeutics?
Rappta Therapeutics is a private company, so its shares have no public market price. Caplight tracks Rappta Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rappta Therapeutics worth (valuation)?
Valuation information for Rappta Therapeutics is not publicly available.
Can I buy Rappta Therapeutics stock?
Rappta Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rappta Therapeutics's last funding round?
Rappta Therapeutics's most recent funding round was Series A on October 13, 2020.
Who are the main investors in Rappta Therapeutics?
Key investors in Rappta Therapeutics include Novo Holdings.
Will Rappta Therapeutics IPO soon?
No public IPO plans have been announced for Rappta Therapeutics.
How can I track Rappta Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Rappta Therapeutics's shares on secondary markets.